Clinical trial
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for…
NCT01626079 · Abbott Medical Devices, Industry · Unknown status
Key facts
| NCT number | NCT01626079 |
|---|---|
| Title | Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS |
| Official title | A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed) |
| Acronym | COAPT |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Mitral Regurgitation, Mitral Valve Regurgitation, Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects, Heart Failure |
| Intervention type | Device |
| Interventions | MitraClip System |
| Enrollment | 776 |
| Start date | Aug 1, 2012 |
| Primary completion | Mar 1, 2019 |
| Completion | Jul 1, 2024 |
| First posted | Jun 22, 2012 |
| Last update posted | Nov 27, 2023 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: